375 related articles for article (PubMed ID: 21448206)
1. The use of Omegaven in treating parenteral nutrition-associated liver disease.
Park KT; Nespor C; Kerner J
J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
[TBL] [Abstract][Full Text] [Related]
2. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
Rollins MD; Scaife ER; Jackson WD; Meyers RL; Mulroy CW; Book LS
Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
[TBL] [Abstract][Full Text] [Related]
4. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.
Gura KM; Duggan CP; Collier SB; Jennings RW; Folkman J; Bistrian BR; Puder M
Pediatrics; 2006 Jul; 118(1):e197-201. PubMed ID: 16818533
[TBL] [Abstract][Full Text] [Related]
5. What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome?
Diamond IR; Pencharz PB; Wales PW
Minerva Pediatr; 2009 Jun; 61(3):263-72. PubMed ID: 19461570
[TBL] [Abstract][Full Text] [Related]
6. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
[TBL] [Abstract][Full Text] [Related]
7. Preventing parenteral nutrition liver disease.
Kelly DA
Early Hum Dev; 2010 Nov; 86(11):683-7. PubMed ID: 20923719
[TBL] [Abstract][Full Text] [Related]
8. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition.
Burns DL; Gill BM
JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):274-80. PubMed ID: 22683685
[TBL] [Abstract][Full Text] [Related]
9. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.
de Meijer VE; Gura KM; Meisel JA; Le HD; Puder M
Arch Surg; 2010 Jun; 145(6):547-51. PubMed ID: 20566974
[TBL] [Abstract][Full Text] [Related]
10. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.
Fallon EM; Le HD; Puder M
Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524
[TBL] [Abstract][Full Text] [Related]
11. Elements of successful intestinal rehabilitation.
Sigalet D; Boctor D; Brindle M; Lam V; Robertson M
J Pediatr Surg; 2011 Jan; 46(1):150-6. PubMed ID: 21238657
[TBL] [Abstract][Full Text] [Related]
12. Is the use of parenteral omega-3 lipid emulsions justified in surgical neonates with mild parenteral nutrition-associated liver dysfunction?
Nasr A; Diamond IR; de Silva NT; Wales PW
J Pediatr Surg; 2010 May; 45(5):980-6. PubMed ID: 20438939
[TBL] [Abstract][Full Text] [Related]
13. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease.
Venick RS; Calkins K
Curr Opin Organ Transplant; 2011 Jun; 16(3):306-11. PubMed ID: 21505340
[TBL] [Abstract][Full Text] [Related]
14. Some new insights in intestinal failure-associated liver disease.
Goulet O; Joly F; Corriol O; Colomb-Jung V
Curr Opin Organ Transplant; 2009 Jun; 14(3):256-61. PubMed ID: 19444108
[TBL] [Abstract][Full Text] [Related]
15. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults.
Xu Z; Li Y; Wang J; Wu B; Li J
Clin Nutr; 2012 Apr; 31(2):217-23. PubMed ID: 22035955
[TBL] [Abstract][Full Text] [Related]
16. Improvement in Parenteral Nutrition-Associated Cholestasis With the Use of Omegaven in an Infant With Short Bowel Syndrome.
Strang BJ; Reddix BA; Wolk RA
Nutr Clin Pract; 2016 Oct; 31(5):647-53. PubMed ID: 27143651
[TBL] [Abstract][Full Text] [Related]
17. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
Orso G; Mandato C; Veropalumbo C; Cecchi N; Garzi A; Vajro P
Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
[TBL] [Abstract][Full Text] [Related]
18. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome.
Diamond IR; Sterescu A; Pencharz PB; Kim JH; Wales PW
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):209-15. PubMed ID: 19179884
[TBL] [Abstract][Full Text] [Related]
19. Prevention of parenteral nutrition-associated liver disease: lipid minimization.
Cober MP; Teitelbaum DH
Curr Opin Organ Transplant; 2010 Jun; 15(3):330-3. PubMed ID: 20386446
[TBL] [Abstract][Full Text] [Related]
20. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.
de Meijer VE; Gura KM; Le HD; Meisel JA; Puder M
JPEN J Parenter Enteral Nutr; 2009; 33(5):541-7. PubMed ID: 19571170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
